IRVINE, Calif., Dec. 1, 2015 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS), a leading global aesthetic device company, announced today that it will host an Analyst Day meeting on Thursday, December 3, 2015 from 8:30 am to 11:30 am ET (registration begins at 8:30 am, formal presentation begins at 9:00 am). The meeting will include a review of the Company's key growth platforms, including UltraShape, PicoWay, and Profound and will feature presentations from management and clinician key opinion leaders.
Attendance is by invitation only. Please RSVP to email@example.com by December 1, 2015 if you are interested in attending.
The meeting will be hosted by Syneron's management team and will feature presentations and Q&A with the following physicians:
- Zena H. Gabriel, MD, Dr. Zena Dermatology, Newport Beach, CA – UltraShape and VelaShape
- Reps B. Sundin, MD, Virginia Institute of Plastic Surgery, Richmond, VA and MBody: Modern Body Contouring and Laser Center, Tysons Corner, VA – UltraShape
- Vic Narurkar, MD, Bay Area Laser Institute, San Francisco, CA – PicoWay
- Macrene Alexiades, MD, PhD, Dermatology and Laser Surgery Center, New York, NY – Profound
The approximate agenda for the meeting includes:
8:30 – 9:00 am Registration and breakfast 9:00 – 11:00 am Management and physician presentations 11:00 – 11:30 am Q&A session
Webcast An audio webcast of the Analyst Day meeting will be accessible through the Investor Relations section on Syneron's website at www.syneron.com beginning at 9:00 am ET on December 3, 2015 and a replay will be available after the event concludes.
About Syneron Candela: Syneron Candela is a leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, tattoo removal, improving the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under three distinct brands, Syneron, Candela and CoolTouch, and has a wide portfolio of trusted, leading products including UltraShape, VelaShape, GentleLase, VBeam Perfecta, PicoWay, Profound and elos Plus.
Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Candela are located in Israel. Syneron Candela also has R&D and manufacturing operations in the U.S. The company markets, services and supports its products in 86 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia,China, Japan, and Hong Kong and distributors worldwide.
For additional information, please visit http://www.syneron-candela.com.
SOURCE Syneron Medical Ltd.